GRI GRI Bio, Inc. Future Price to Earnings
The forward P/E ratio of GRI Bio, Inc. (GRI) reflects the price action of an asset whose demand in fibrosis therapy remains independent of market cycles, with a current value of 0.00. The scientific authority of GRI Bio, Inc. (GRI) is based on unique molecules for T-cell regulation. Business efficiency is supported by a lean staff of immunologists incentivized by long-term options.
GRI Bio Corporation (GRI) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- market capitalization data:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
- company profitability and valuation multiples indicators:
GRI - Net Financial Result|Future Profit GRI Bio, Inc.|GRI - Company Value to Net Income|Forward P/E Multiple GRI Bio Corp|GRI - Price/Earnings to Growth Ratio|EV/EBITDA Multiple GRI Bio Inc|GRI - Operating income before deduction of amortization|Earnings per share for the last twelve months GRI Bio|GRI - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months gribio.com|GRI - Earnings per share increase in current year|Earnings growth forecast for next year GRI Bio, Inc.
Analysis of all company metrics:GRI Bio
GRI Bio, Inc. (GRI) is a high-tech biotech company with a strong academic foundation and optimized clinical research costs. By analyzing the issuer's forward P/E, an investor assesses the cost of one dollar of expected earnings, which allows for a comparison of current market capitalization with future cash flows and confirms the effectiveness of management's lean resource management strategy.
Competitor analysis
Forward P/E Multiple ARGX|Market Cap to Projected Earnings BioNTech Inc.|Future Price to Earnings abivax.com ABVX|ADMA - Projected Price to Earnings|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|KNSA (Kiniksa) - Projected Price to Earnings|Grifols SA (GRFS) - Forward P/E Multiple|Future Price to Earnings Adaptive Biotechnologies Corp|Price to Future Earnings Ratio CLDX (Celldex Corp)|Forward P/E Multiple AUPH|BCRX - Projected Price to Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Forward Price to Earnings Multiple Dianthus Therapeutics Inc|PHVS - Future Price to Earnings|Future Price to Earnings Multiple ABCL (AbCellera Biologics)|TRML: Forward P/E Multiple|PGEN - Market Cap to Projected Earnings|Projected Price to Earnings PHAR|NKTR: Future Price to Earnings Multiple|Forward P/E Multiple UPB|Future Price to Earnings ZBIO (Zenas Corp)|Forward P/E Multiple IMNM (Immunome, Inc.)|Market Cap to Projected Earnings gossamerbio.com (GOSS)|KALV - Future Price to Earnings|Projected Price to Earnings Ratio Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Projected Price to Earnings|Savara Pharma - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|anaptysbio.com (ANAB) - Market Cap to Projected Earnings|Future Price to Earnings Astria Therapeutics, Inc. (ATXS)|enGene Holdings Inc - Price to Future Earnings Ratio|Forward P/E Multiple RAPT (RAPT Therapeutics, Inc.)|JBIO - Projected Price to Earnings|ACRS: Projected Price to Earnings|Market Cap to Projected Earnings kyvernatx.com KYTX|TLSA: Forward P/E Multiple|Forward Price to Earnings Multiple Cabaletta Bio Inc. CABA|Future Price to Earnings Ventyx Bio|THTX: Future Price to Earnings Multiple|Forward P/E Multiple AVTX|Market Cap to Projected Earnings eledon.com|Future Price to Earnings Agenus Inc. AGEN|CLYM (Climb Bio Inc.) - Price to Expected Earnings Ratio|Zura Bio Limited - Forward P/E Multiple|Future Price to Earnings Multiple ATYR (aTyr Pharmaceuticals)|ADAG: Forward P/E Multiple|Ikena Oncology (IMA) - Forward P/E Multiple|Future Price to Earnings Shattuck Labs Inc|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Biopharma (CNTB)|Projected Price to Earnings immunic-therapeutics.com IMUX|Forward P/E Multiple ATRA (Atara Bio)|Forward P/E Multiple InflaRx NV IFRX|XFOR: Projected Price to Earnings|Future Price to Earnings Multiple ACET (Adicet Bio)|CELU: Forward P/E Multiple|INMB - Market Cap to Projected Earnings|Future Price to Earnings Barinthus Biotherapeutics|Projected Price to Earnings kezarlifesciences.com (KZR)|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|Projected Price to Earnings Akari Therapeutics PLC AKTX|Enlivex Therapeutics Ltd. - Projected Price to Earnings|Forward P/E Multiple Q32 Bio Inc QTTB|GOVX - Future Price to Earnings|EDSA (edesabiotech.com) - Price to Future Earnings Ratio|IBIO: Forward P/E Multiple|Projected Price to Earnings Ratio Carisma Therapeutics Inc. (CARM)|XTLB (XTL Biopharmaceuticals, Ltd.) - Forward P/E Multiple|BOLT - Forward Price to Earnings Multiple|Future Price to Earnings HCW Biologics Inc. (HCWB)|APVO (aptevotherapeutics.com) - Future Price to Earnings Multiple|Forward P/E Multiple AIM (AIM ImmunoTech)|Market Cap to Projected Earnings Aditxt Inc. (ADTX)|XRTX: Projected Price to Earnings|Future Price to Earnings Multiple HIND (Vyome Therapeutics)|REVB: Forward P/E Multiple|INDP (indaptusrx.com) - Future Price to Earnings|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|CalciMedica Corp (CALI) - Market Cap to Projected Earnings|Future Price to Earnings Affimed (AFMD)|ALLK - Projected Price to Earnings Ratio|HOOKIPA Pharma - Projected Price to Earnings|Future Price to Earnings Multiple IGMS|iTeos Therapeutics, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Ocean Biomedical Inc OCEA|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|Price to Future Earnings Ratio THRD
